FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures ...

Factor Bioscience Inc., a Cambridge-based biotechnology company focused on using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today announced its participation ...

The immune system is a complex response of various cells that detect and elicit mechanisms to eliminate disease. This ...

Researchers from Tomsk Polytechnic University, together with their colleagues from Mexico, studied and described molecular ...

FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures ...

Researchers have developed a new way to understand how cells survive heat stress by tracking how genes shift under changing ...

Scar-driven changes in joint tissue may underlie treatment resistance in rheumatoid arthritis, opening the door to new ...

This useful study identified XAP5 as an ancient transcriptional regulator critical for primary ciliogenesis. The evidence supporting the conceptual framework linking evolutionary conservation to ...

There are differences between familial and idiopathic pulmonary fibrosis in terms of cluster of differentiation 20 and CD3 expression.

"Our goal is to provide relief and healing to patients with this terrible disease," said Dr. Bruce Riser, CEO of BLR Bio and ...

A newly discovered pair of stem cell lineages drives the formation of both tooth roots and the bone that anchors them. Understanding how these cells switch roles could pave the way for regenerating ...